微小RNA-206通过调控小鼠Met原癌基因与细胞周期蛋白依赖性激酶6的表达预防肝细胞癌的发生
在两种肝细胞癌小鼠模型、人肝细胞癌组织及人肝癌细胞系中,微小RNA-206表达下调;其通过抑制cMET、CCND1和CDK6表达,延缓细胞周期、诱导凋亡并抑制三种人肝癌细胞系增殖;全身给药可完全预防cMyc与AKT/Ras肝癌小鼠的肿瘤发生,而对照组小鼠100%死于致死性肿瘤负荷。
要点
- 微小RNA-206在两种肝癌小鼠模型肝脏、人肝癌组织及人肝癌细胞系中低表达。
- cMET、CCND1和CDK6为微小RNA-206的功能性靶点,抑制后延缓细胞周期并诱导凋亡。
- 全身给予微小RNA-206完全预防cMyc与AKT/Ras肝癌小鼠的肿瘤发生,对照小鼠100%死于肿瘤负荷。
核心结论
- 本研究定义了微小RNA-206在预防肝细胞癌生长中的潜在关键作用,并提示其可作为该恶性肿瘤的潜在治疗策略。
研究设计与样本
- 研究采用两种肝细胞癌小鼠模型(cMyc与AKT/Ras)、人肝细胞癌组织及三种人肝癌细胞系,结合生物信息学预测与分子细胞学方法。
主要发现
- 微小RNA-206在两种肝癌小鼠模型肝脏、人肝癌组织及人肝癌细胞系中表达下调。
- 微小RNA-206通过抑制cMET、CCND1和CDK6表达,延缓细胞周期进展、诱导凋亡并抑制三种人肝癌细胞系增殖。
- 全身给予微小RNA-206完全预防cMyc与AKT/Ras肝癌小鼠的肿瘤发生,而对照小鼠100%死于致死性肿瘤负荷。
- 在cMyc与AKT/Ras肝癌小鼠肝脏中重新引入cMet或Cdk6,可恢复被微小RNA-206抑制的肝细胞癌生长。
- 微小RNA-206过表达在异种移植瘤与cMyc肝癌小鼠中显示出显著的治疗效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide, and therapeutic agents for this malignancy are lacking. MicroRNAs play critical roles in carcinogenesis and present tremendous therapeutic potential. Here, we report that microRNA-206 is a robust tumor suppressor that plays important roles in the development of HCC by regulating cell-cycle progression and the cMet signaling pathway. MicroRNA-206 was underexpressed in livers of two HCC mouse models, human individuals bearing HCC, and human HCC cell lines. Combining bioinformatic prediction and molecular and cellular approaches, we identified cMET (Met proto-oncogene), cyclin D1 (CCND1), and cyclin-dependent kinase 6 (CDK6) as functional targets of microRNA-206. By inhibiting expression of cMET, CCND1, and CDK6, microRNA-206 delayed cell-cycle progression, induced apoptosis, and impaired proliferation of three distinct human HCC cell lines. Systemic administration of microRNA-206 completely prevented HCC development in both cMyc and V-Akt murine thymoma viral oncogene homolog 1/neuroblastoma RAS viral oncogene homolog (AKT/Ras) HCC mice, whereas 100% of control mice died from lethal tumor burdens. Conversely, reintroduction of cMet or Cdk6 into livers of cMyc and AKT/Ras HCC mice recovered growth of HCC inhibited by microRNA-206. These results strongly suggested that cMet and Cdk6 were two functional targets that mediated the inhibitory effect of microRNA-206 on the development of HCC. MicroRNA-206 overexpression demonstrated a profound therapeutic effect on HCC in xenograft and cMyc HCC mice. CONCLUSION: In summary, this study defines a potentially critical role of microRNA-206 in preventing the growth of HCC and suggests its use as a potential therapeutic strategy for this malignancy. (Hepatology 2017;66:1952-1967).
引用
- Wu H, Tao J, Li X, et al. MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice. Hepatology. 2017. PMID: 28714063. doi:10.1002/hep.29374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。